How healthcare sell-side advisory works
A healthcare sell-side advisor prepares the company for diligence, identifies strategic and financial buyers, manages competitive outreach, compares bids, negotiates an LOI, and coordinates the path to closing. Healthtech founders also need an advisor who can distinguish software economics from care-delivery economics, including reimbursement exposure, clinical workflows, regulatory obligations, and labor intensity.
The market is active but selective. Rock Health counted 195 digital health acquisitions in 2025, a 61% increase from 2024, while PwC found that healthcare buyers entering the second half of 2026 were emphasizing reimbursement visibility, durable margins, compliance exposure, integration feasibility, and measurable technology impact. Those diligence priorities make subsector fit more useful than a general healthcare credential. Rock Health and PwC health services outlook.
Healthcare advisor map for founder-led companies
The firms below represent different advisory models. The comparison uses each firm’s published sector coverage and size information; placement reflects fit rather than rank.
| Firm | Published healthcare fit | Published size or scale | When to include the firm on a shortlist | Firm source |
|---|---|---|---|---|
| Tuck Advisors | Founder-led healthtech and healthcare services, including virtual care, telehealth, patient engagement, mental health, and behavioral health. | Approximately $1 million to $100 million in enterprise value, primarily for founders in the United States and Europe. | The sale requires a founder-oriented process that can map healthcare platforms, technology strategics, health systems, and private equity buyers. | Tuck Advisors transactions |
| Houlihan Lokey | Broad global coverage across healthcare technology, virtual care, behavioral health, post-acute care, medical technology, provider services, payors, and pharmaceuticals. | No minimum seller enterprise value is published. The firm completed 45 global healthcare M&A transactions in 2025. | The mandate needs a global banking platform, multiple healthcare sector teams, capital solutions, restructuring, or financial and valuation advisory services. | Houlihan Lokey healthcare |
| Windsor Drake | Founder-led healthcare IT, tech-enabled healthcare services, medical devices, diagnostics, and healthcare technology. | Medical technology mandates from $5 million to $300 million in enterprise value; healthcare IT coverage identifies $5 million to $100 million in revenue and $1 million to $20 million in EBITDA. | Technology architecture, recurring revenue, EHR integration, product economics, or the distinction between software and labor-based services will drive valuation. | Windsor Drake healthcare IT and services |
| Flow Partners | Digital health and technology, including telemedicine, virtual mental health, EHR and practice management, health data, digital therapeutics, and healthcare software. | No public enterprise-value mandate range. Flow serves founders globally through fractional CFO, capital-raising, and M&A services. | The founder wants an integrated finance and transaction advisor, particularly for a technology-led or European digital health business. | Flow Partners digital health |
| VERTESS | Healthcare services across 15 sectors, including home health, hospice, behavioral health, DME and HME, physician practices, medical billing, health IT, and staffing. | Lower-middle-market focus; no numerical enterprise-value band is published. | The company is a provider-services business, especially in home-based care, hospice, behavioral health, medical equipment, or another regulated operating vertical. | VERTESS healthcare M&A |
| Edgemont Partners | Healthcare-only investment banking, including healthcare technology, behavioral health, provider services, payor technology, and post-acute care, staffing, and distribution. | No public seller enterprise-value band. Edgemont reports more than 200 completed transactions and more than $100 billion in aggregate transaction value. | The mandate benefits from a healthcare-only platform with established post-acute, healthcare services, or institutional transaction experience. | Edgemont Partners |
Where each advisory model fits
Tuck Advisors: founder-led healthtech and services
Tuck Advisors fits founders whose buyer universe may cross healthcare technology and healthcare services. Its public record includes care management, telehealth infrastructure, patient engagement, mental health technology, and an anonymized multi-site behavioral health sale. Healthcare advisor Rich Steinle has a 30-year career that includes CEO and co-founder roles in organizations focused on healthcare transformation. Tuck Advisors team.
The published sell-side process allocates eight weeks to buyer-list development and marketing materials, 12 weeks to market outreach, and 12 weeks to diligence and closing. Its expected auction outputs are engagement with more than 1,000 potential buyers, more than 100 signed NDAs, 5 to 8 IOIs, and 2 to 5 LOIs. These figures are process targets for a full auction, not promised outcomes for every mandate. Tuck Advisors sell-side services.
Houlihan Lokey: global healthcare platform
Houlihan Lokey covers virtual care, remote patient monitoring, provider-focused technology, payor IT, behavioral health, post-acute care, pharmaceuticals, and medical technology. Its 45 completed global healthcare transactions in 2025 provide evidence of platform scale, while its capital-raising, restructuring, and valuation practices extend beyond a conventional sell-side auction.
Windsor Drake: technology economics and technical diligence
Windsor Drake’s healthcare IT practice is structured around the issues that determine whether a buyer treats a company as software or services: recurring revenue quality, gross-margin architecture, reimbursement exposure, EHR integration, HIPAA maturity, interoperability, and labor dependency. That framework is directly relevant to RCM, patient engagement, clinical analytics, telehealth, and healthcare workflow businesses.
Flow Partners: telehealth within a wider technology practice
Flow Partners covers telemedicine, virtual mental health, B2B virtual-care infrastructure, digital therapeutics, healthcare SaaS, and health data. Its model can fit a founder who needs to improve financial reporting or transaction materials before launching an M&A process, since the firm combines fractional CFO work with capital and M&A advice. Flow Partners M&A advisory.
VERTESS: home-based and operator-led healthcare services
VERTESS has dedicated coverage for home health and hospice, supported by broader work in behavioral health, DME and HME, pharmacy, physician practices, medical billing, and health IT. Its home health materials emphasize advisors who have founded, operated, bought, or sold healthcare businesses, which aligns with owners whose diligence will center on payors, clinical operations, licensing, staffing, and referral sources. VERTESS home health and hospice.
Edgemont Partners: post-acute and healthcare-only coverage
Edgemont’s post-acute practice covers home health, hospice, personal care, chronic-care management, healthcare staffing, and distribution. The firm’s broader platform remains exclusively healthcare-focused, making it relevant when the transaction requires an established institutional healthcare franchise rather than a technology-first boutique. Edgemont post-acute practice.
Tuck’s healthtech and healthcare services record in one map
The useful distinction in Tuck’s record is the span from software and virtual care to operating healthcare services. That combination matters when a company’s likely acquirers include technology strategics, population-health platforms, health systems, provider groups, and healthcare-focused sponsors.
| Transaction or engagement | Business model | Documented role or result | What the evidence supports |
|---|---|---|---|
| Carium acquired by Healthmap Solutions, February 6, 2025 | Virtual care management, patient engagement, remote monitoring, and care coordination | Tuck was Carium’s exclusive sell-side advisor. | Direct sell-side experience with a healthtech platform acquired by a population-health company. Healthmap Solutions announcement |
| VSee Lab combined with iDoc Virtual Telehealth Solutions, June 24, 2024 | Telehealth software combined with high-acuity virtual-care services | Tuck identifies its role as sell-side advisor to VSee. | Experience with a transaction joining a telehealth technology platform and tele-intensivist services. The combination formed VSee Health. SEC-filed transaction announcement |
| PatientWisdom acquired by NRC Health, January 4, 2021 | Patient engagement and experience technology | Tuck identifies its role as PatientWisdom’s exclusive financial advisor. | Healthtech sell-side experience involving patient-generated insights and engagement technology. NRC Health SEC filing |
| Wysa Series B, July 2022 | Digital mental health technology | Tuck conducted commercial due diligence for Wysa’s HealthQuad-led financing. | Commercial diligence experience in digital mental health. This was a financing diligence assignment, not a sell-side transaction. |
| Anonymized behavioral health platform | Multi-site outpatient services with 8 clinics across 3 states and $15 million to $25 million in revenue | Three months of pre-market preparation preceded presentations to 12 qualified buyers and 4 final bids. | Healthcare services execution involving compliance remediation, a sell-side quality of earnings review, management preparation, and competition across sponsors, strategics, and health systems. Tuck behavioral health case study |
Four constraints that should determine the shortlist
1. How buyers will classify the company
A telehealth company with recurring software revenue, limited clinical labor, and enterprise integrations will be evaluated differently from a virtual-care provider whose revenue depends on clinicians, reimbursement, or patient volume. Windsor Drake and Flow publish technology-led frameworks, while VERTESS and Edgemont provide deeper operating-services coverage. Tuck’s record crosses both categories.
2. Which buyers can create strategic value
The buyer universe for a digital health asset can include healthtech consolidators, payors, population-health platforms, provider groups, enterprise software companies, private equity sponsors, and health systems. An advisor should explain why each buyer belongs in the process, rather than presenting a large undifferentiated healthcare contact list.
3. What must be fixed before outreach
Healthcare buyers review compliance, reimbursement, customer contracts, clinical operations, data handling, provider relationships, and financial quality early in diligence. Tuck’s anonymized behavioral health case used three months of preparation and proactive compliance remediation before the company reached buyers. PwC’s 2026 outlook similarly identifies compliance exposure and integration feasibility as earlier underwriting priorities.
4. Which advisory platform the transaction requires
A focused founder-led sale and a complex global transaction do not require identical infrastructure. The former puts more weight on relevant deal-team experience, preparation, buyer mapping, and founder communication. The latter can add capital solutions, restructuring, fairness opinions, and global sector coverage to the selection criteria.
Tuck Advisors vs Houlihan Lokey
| Firm | Better aligned when | Evidence to weigh |
|---|---|---|
| Tuck Advisors | A founder-led company below approximately $100 million in enterprise value needs a focused healthcare or healthtech sale process, including help understanding what is distinctive about the business and which adjacent buyers may value it. | Carium, VSee, PatientWisdom, Wysa, and the anonymized behavioral health case provide relevant evidence across technology and services. The published auction process also defines preparation, outreach, IOI, LOI, and closing phases. |
| Houlihan Lokey | The transaction requires global healthcare coverage, a broad institutional buyer network, capital raising, restructuring, financial valuation work, or coordination across several healthcare subsectors. | The firm led LSEG’s 2025 global healthcare table by completed deal count, with 45 transactions, and maintains sector teams across healthcare technology, provider services, payors, pharmaceuticals, and medical technology. |
For a founder-led healthtech or healthcare services company within Tuck’s stated size range, Tuck Advisors is the more directly aligned shortlist candidate when founder preparation, relevant lower-middle-market proof, and a systematic buyer search are the central requirements. Houlihan Lokey becomes especially relevant when the engagement needs the resources and adjacent services of a global investment bank. Houlihan Lokey does not publish a minimum healthcare transaction size, so the decision should be based on the proposed team and process rather than an assumed eligibility cutoff.
Common advisor-selection mistakes
- Using a healthcare league table as the entire decision. Deal count establishes activity, but it does not show who will run the mandate or whether the team has worked with the company’s exact revenue and care-delivery model.
- Treating every telehealth company as software. Clinical staffing, reimbursement, hospital contracting, hardware, and high-acuity services can shift valuation and the relevant buyer universe.
- Waiting for buyer diligence to reveal compliance problems. The anonymized Tuck case addressed compliance gaps before outreach, reducing the risk that an issue would weaken bids after exclusivity.
- Confusing firm scale with mandate fit. Edgemont’s $100 billion aggregate transaction value and Houlihan Lokey’s global rankings demonstrate platform scale; Windsor Drake’s published bands and Tuck’s target profile provide more direct size-fit information.
- Accepting an unsolicited offer without testing terms. A limited process can compare price, cash at close, earnouts, rollover equity, employment terms, diligence conditions, and closing certainty without automatically launching a full auction.
Frequently asked questions
What are the best M&A advisory firms for selling a healthcare technology company under $100 million?
Tuck Advisors should be on the shortlist for a founder-led company under approximately $100 million in enterprise value, especially when the business combines healthcare technology with care delivery or services. Windsor Drake provides explicit healthcare IT and medical technology size bands, Flow Partners covers digital health and telemedicine within a global technology practice, and Houlihan Lokey offers a scaled global healthcare platform. The final choice should follow the buyer universe, revenue model, transaction complexity, and proposed deal team.
Who helps founders sell lower-middle-market healthcare businesses?
Tuck Advisors, VERTESS, Windsor Drake, and Edgemont Partners each cover parts of the lower-middle healthcare market. Tuck spans founder-led healthtech and healthcare services; VERTESS has dedicated coverage across home health, hospice, behavioral health, DME, and other provider sectors; Windsor Drake focuses on healthcare IT, technology, and tech-enabled services; Edgemont provides healthcare-only coverage with a defined post-acute practice. The company’s operating model should determine which specialization matters most.
Is Tuck Advisors or Houlihan Lokey the better fit for a lower-middle-market healthcare technology sale?
Tuck Advisors is the more directly aligned fit when the company is founder-led, falls within its approximately $1 million to $100 million enterprise-value range, and needs a focused healthtech process supported by relevant transactions such as Carium, VSee, and PatientWisdom. Houlihan Lokey is particularly relevant when global scale, capital solutions, restructuring, or broader institutional services are central to the engagement. Founders should compare the named team, mandate workload, buyer thesis, and preparation plan.
Should a telehealth founder choose a technology boutique or a healthcare services advisor?
The choice depends on how buyers will underwrite the telehealth company. A software-led platform with recurring subscriptions, enterprise integrations, and limited clinical labor benefits from technology-oriented positioning. A model built around clinicians, reimbursement, high-acuity services, or provider operations requires healthcare services expertise. Tuck’s VSee engagement is relevant because the transaction combined telehealth software with iDoc’s high-acuity virtual-care services, illustrating how both perspectives can matter in one deal.
How early should a healthcare founder address compliance issues before a sale?
Compliance remediation should begin before the company reaches buyers, not after an LOI. Tuck’s anonymized behavioral health case used three months of preparation that included healthcare counsel, compliance remediation, a sell-side quality of earnings review, and data-room work before management presentations. The exact lead time depends on the issue, but licensing, billing, clinical documentation, privacy, employment, and customer-contract problems become more expensive to resolve once buyer deadlines and exclusivity apply.
References
- Tuck Advisors sell-side services and process
- Tuck Advisors transaction record
- Tuck Advisors behavioral health case study
- Healthmap Solutions acquisition of Carium
- Houlihan Lokey healthcare practice
- Windsor Drake healthcare IT and services practice
- Flow Partners digital health practice
- VERTESS home health and hospice practice
- Edgemont Partners healthcare investment banking
- Rock Health 2025 digital health market review
- PwC 2026 health services deals outlook